Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Sutherland

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Annals of Surgery|October 1, 1994
Regional chemotherapy for melanoma. A 35-year experienceE T Krementz, R D Carter, C M Sutherland, et al.
Journal of Surgical Oncology|August 1, 1982
In vivo delayed hypersensitivity reactions to partially purified human melanoma antigensC M Sutherland, S P Leong, S R Cooperband, et al.
Oncology|January 1, 1983
Serological detection of common human melanoma membrane antigens by microcomplement fixation and immunofluorescenceS P Leong, S R Cooperband, P J Deckers, et al.
Cancer Research|June 1, 1979
Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cellsS P Leong, S R Cooperband, P J Deckers, et al.
Oncology|January 1, 1979
Effect of different fixatives on the localization of human melanoma antigens by immunofluorescenceS P Leong, S R Cooperband, P J Deckers, et al.
American Journal of Surgery|July 1, 1993
Acral lentiginous melanomaC M Sutherland, F J Mather, J H Muchmore, et al.
Surgery, Gynecology & Obstetrics|August 1, 1992
Patient characteristics, methods of diagnosis and treatment of melanoma in the United StatesC M Sutherland, J S Chmiel, D E Henson, et al.
Cancer Research|December 1, 1978
Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cellsS K Liao, S P Leong, C M Sutherland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Annals of Surgery|October 1, 1994
Regional chemotherapy for melanoma. A 35-year experienceE T Krementz, R D Carter, C M Sutherland, et al.
Journal of Surgical Oncology|August 1, 1982
In vivo delayed hypersensitivity reactions to partially purified human melanoma antigensC M Sutherland, S P Leong, S R Cooperband, et al.
Oncology|January 1, 1983
Serological detection of common human melanoma membrane antigens by microcomplement fixation and immunofluorescenceS P Leong, S R Cooperband, P J Deckers, et al.
Cancer Research|June 1, 1979
Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cellsS P Leong, S R Cooperband, P J Deckers, et al.
Oncology|January 1, 1979
Effect of different fixatives on the localization of human melanoma antigens by immunofluorescenceS P Leong, S R Cooperband, P J Deckers, et al.
American Journal of Surgery|July 1, 1993
Acral lentiginous melanomaC M Sutherland, F J Mather, J H Muchmore, et al.
Surgery, Gynecology & Obstetrics|August 1, 1992
Patient characteristics, methods of diagnosis and treatment of melanoma in the United StatesC M Sutherland, J S Chmiel, D E Henson, et al.
Cancer Research|December 1, 1978
Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cellsS K Liao, S P Leong, C M Sutherland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Pageof 6